<SEC-DOCUMENT>0001607062-15-000302-index.html : 20150707
<SEC-HEADER>0001607062-15-000302.hdr.sgml : 20150707
<ACCEPTANCE-DATETIME>20150707171119
ACCESSION NUMBER:		0001607062-15-000302
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150707
FILED AS OF DATE:		20150707
DATE AS OF CHANGE:		20150707
EFFECTIVENESS DATE:		20150707

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENEREX BIOTECHNOLOGY CORP
		CENTRAL INDEX KEY:			0001059784
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820490211
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-25169
		FILM NUMBER:		15977141

	BUSINESS ADDRESS:	
		STREET 1:		33 HARBOUR SQ
		STREET 2:		STE 202
		CITY:			TORONTO ONTARIO CANADA
		STATE:			A1
		ZIP:			M5J 2G2
		BUSINESS PHONE:		4163642551

	MAIL ADDRESS:	
		STREET 1:		33 HARBOUR SQ
		STREET 2:		STE 202
		CITY:			TORONTO ONTARIO CA
		STATE:			A1
		ZIP:			M5J 2G2
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>gnbt60215sch14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: gnbt60215sch14a.htm

</DOCUMENT>
</SEC-DOCUMENT>